COMBIGAN (brimonidine tartrate; timolol maleate) Allergan Patent: 9,474,751 Expiration: Apr 19, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Exp…
Drug Patent Expirations for the Week of April 17, 2022 Read Post »
This chart shows the drugs with the most patents in South Korea. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical drugs have the most drug patents in South Korea?…
Which pharmaceutical drugs have the most drug patents in South Korea? Read Post »
Bendamustine hydrochloride is the generic ingredient in three branded drugs marketed by Cephalon and Eagle Pharms and is included in three NDAs. There are twenty-five patents protecting this compound. Drug…
The post New tentative approval for Apotex In…
New tentative approval for Apotex Inc drug bendamustine hydrochloride Read Post »
Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent for Abbvie Inc drug RINVOQ appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for KALYDECO Kalydeco is a drug marketed by Vertex Pharms Inc and Vertex Pharms and is included in two NDAs. It is available from one supplier.…
The post New patent for Vertex Pharms drug KALYDECO appeared first on DrugPa…
This chart shows the pharmaceutical companies with the most patents in Peru. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug patents…
Which pharmaceutical companies have the most drug patents in Peru? Read Post »
Annual Drug Patent Expirations for VIZIMPRO Vizimpro is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are two patents protecting…
The post New patent for Pfizer drug VIZIMPRO appeared first on DrugPaten…
Annual Drug Patent Expirations for ARISTADA+INITIO+KIT Aristada Initio Kit is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Alkermes Inc drug ARISTADA INITIO KIT appear…
New patent for Alkermes Inc drug ARISTADA INITIO KIT Read Post »
Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Teva Pharm drug ARMONAIR RESPICLICK a…
New patent for Teva Pharm drug ARMONAIR RESPICLICK Read Post »
Annual Drug Patent Expirations for AIRDUO+RESPICLICK Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from four suppliers. There are sixteen…
The post New patent for Teva Pharm drug AIRDUO RESPICLICK appear…
New patent for Teva Pharm drug AIRDUO RESPICLICK Read Post »
Get new actionable insights and updates from BiotechBlog
